<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1035</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>10544112</PubmedId>
            <Abstract>We investigated the antigenic maturation of rabies virus N protein, for which we used some conformational epitope-specific monoclonal antibodies (MAbs) and an MAb (5-2-26) against a phosphorylation-dependent linear epitope. Infected cells were lysed with a deoxycholate-free lysis buffer and separated by ultracentrifugation into the soluble top and the nucleocapsid fractions. None of the study MAbs recognized N proteins in the top fraction, whereas nucleocapsid-associated N proteins were recognized by all of the MAbs. Immunoprecipitation with polyclonal anti-N antibodies coprecipitated the P proteins from the top fraction, indicating that soluble N proteins are mostly associated with the P protein. The N proteins dissociated from both the N-P complex and nucleocapsids were recognized by none of the study MAbs, whereas the MAb 5-2-6 recognized the SDS-denatured N proteins of the nucleocapsid but not of the top fraction. In addition, the phosphorylation-deficient mutant N proteins were shown to be similarly accumulated as the wild-type N proteins into the viral inclusion bodies, defined as the virus-specific structures composed of viral nucleocapsids, that are produced in the cytoplasm of the infected cells. Based on these results, we believe that newly synthesized N proteins are not immediately phosphorylated at serine-389 (a common phosphorylation site) but are first associated with the P protein. After being used for encapsidation of the viral RNA, the N proteins undergo conformational changes, whereby epitopes for the conformation-specific MAbs are formed and become phosphorylated at serine-389.</Abstract>
            <ArticleYear>1999</ArticleYear>
            <ArticlePages>395-407</ArticlePages>
            <ArticleTitle>Nucleocapsid formation and/or subsequent conformational change of rabies virus nucleoprotein (N) is a prerequisite step for acquiring the phosphatase-sensitive epitope of monoclonal antibody 5-2-26.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Kawai</LastName>
                    <ForeName>A</ForeName>
                </Author>
                <Author>
                    <LastName>Toriumi</LastName>
                    <ForeName>H</ForeName>
                </Author>
                <Author>
                    <LastName>Tochikura</LastName>
                    <ForeName>T S</ForeName>
                </Author>
                <Author>
                    <LastName>Takahashi</LastName>
                    <ForeName>T</ForeName>
                </Author>
                <Author>
                    <LastName>Honda</LastName>
                    <ForeName>Y</ForeName>
                </Author>
                <Author>
                    <LastName>Morimoto</LastName>
                    <ForeName>K</ForeName>
                </Author>
            </Authors>
            <Affiliations>Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Sakyo-ku, 606-8501, Japan. akawai@pharm.kyoto-u.ac.jp.</Affiliations>
            <ArticleChemicalList>Antibodies, Monoclonal;Antigens, Viral;Epitopes;Molecular Chaperones;Nucleocapsid Proteins;P phosphoprotein, Rabies virus;Phosphates;Phosphoproteins;Viral Structural Proteins;nucleocapsid protein, Rabies virus;Phosphoric Monoester Hydrolases</ArticleChemicalList>
            <ArticleMeshHeadingsList>Animals; Antibodies, Monoclonal(immunology); Antigens, Viral(chemistry; genetics; immunology; metabolism); Blotting, Western; Cell Fractionation; Cell Line; Cricetinae; Epitopes(immunology); Fluorescent Antibody Technique; Molecular Chaperones; Nucleocapsid(chemistry; genetics; immunology; metabolism); Nucleocapsid Proteins; Phosphates(metabolism); Phosphoproteins(metabolism); Phosphoric Monoester Hydrolases(metabolism); Phosphorylation; Precipitin Tests; Protein Binding; Protein Conformation; Rabies virus(genetics; immunology; metabolism); Solubility; Time Factors; Viral Structural Proteins(metabolism)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>263</Volume>
                <Issue>2</Issue>
                <Title>Virology</Title>
                <Issn>1096-0341</Issn>
                <MedlineTa>Virology</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>Rabies N protein S389</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>S389</DiscontinuousResidues>
                        <ModifiedResidues>S389</ModifiedResidues>
                        <Modifications>Phosphorylation|PHOS</Modifications>
                        <SourceMolecule>
                            <GenBankId>P06025.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11296</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Text p.397</LocationOfData>
                <EpitopeId>153560</EpitopeId>
                <ReferenceRegion>S389</ReferenceRegion>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Partial Epitope</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figures 2, 3, 4, 5, 6, 7, 8, 9 and 10</LocationOfData>
                        <BCellId>1031801</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11296</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Generation of the monoclonal antibody was previously described in the cited references Kawai et al., Microbiol Immunol. 1997;41(1):33-42 [PMID: 9087966] and Ni et al., Microbiol Immunol. 1995;39(9):693-702 [PMID: 8577283].</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>39</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope-specific mAb precipitated wild-type nucleoprotein, but not single residue mutants S389A or S389T nucleoproteins, confirming this residue is critical for mAb binding.  The mAb only reacted with the nucleocapsid fraction of rabies virus-infected BHK-21 cells.  It was also shown that phosphorylation at the epitope residue was required for the mAb recognition.  Western blots showed similar results.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Ascitic Fluid</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>5-2-26</AssayedAntibodyName>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <ModifiedResidues>S389</ModifiedResidues>
                                        <Modifications>Phosphorylation|PHOS</Modifications>
                                        <Molecule>
                                            <GenBankId>P06025.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>11296</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <TransfectedCell>
                                    <SubType>Transfected Cell</SubType>
                                    <CellType>Fibroblast</CellType>
                                    <CellSourceOrganismId>10026</CellSourceOrganismId>
                                </TransfectedCell>
                            </AntigenContainingObject>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 10</LocationOfData>
                        <BCellId>1864303</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11296</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Generation of the monoclonal antibody was previously described in the cited references Kawai et al., Microbiol Immunol. 1997;41(1):33-42 [PMID: 9087966] and Ni et al., Microbiol Immunol. 1995;39(9):693-702 [PMID: 8577283].</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>38</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope-specific mAb reacted with Rabies virus Nishigahara-infected BHK-21 cells.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Ascitic Fluid</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>5-2-26</AssayedAntibodyName>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Sibling</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>11298</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <InfectedCell>
                                    <SubType>Infected Cell</SubType>
                                    <CellType>Fibroblast</CellType>
                                    <SourceOrganismId>10026</SourceOrganismId>
                                </InfectedCell>
                            </AntigenContainingObject>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

